NCT00089401View on ClinicalTrials.gov

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

November 30, 2006

Study Completion Date

March 31, 2008

Conditions
Colorectal CancerMetastatic Cancer
Interventions
DRUG

isolated perfusion

DRUG

melphalan

PROCEDURE

conventional surgery

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00089401 - Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver | Biotech Hunter | Biotech Hunter